Ion Exchange (India) Limited has entered into a strategic technology transfer agreement with MANN + HUMMEL. This collaboration focuses on the domestic manufacturing of advanced PVDF Ultrafiltration (UF) membranes and Membrane Bioreactor (MBR) systems. By localizing the production of these high-performance technologies at its Goa facility, the company aims to enhance its HYDRAMEM® product portfolio, reduce import dependence, and significantly improve supply chain reliability and delivery timelines for its customers.
Boosting Localized Membrane Manufacturing
As part of its long-term strategic objectives, Ion Exchange has secured a technology transfer agreement to manufacture globally benchmarked membrane solutions. The partnership with MANN + HUMMEL allows the company to integrate advanced technology into its existing HYDRAMEM® solutions, expanding its capabilities in Ultrafiltration (UF) and Membrane Bioreactor (MBR) systems.
Strategic Implementation and Financials
Production is set to take place at the company’s expanded HYDRAMEM® facility in Goa. This state-of-the-art facility will handle the system integration and commercialization of PVDF hollow fiber ultrafiltration membranes and UltraSKID systems. Under the terms of the agreement, Ion Exchange will pay a technology transfer fee of 7.5% on revenue generated from the products manufactured under this partnership.
Benefits for the Market
The collaboration is expected to provide substantial benefits by offering an integrated portfolio of membrane-based technologies, including Reverse Osmosis (RO) systems. By moving from imported solutions to locally manufactured, high-performance technology, the company ensures faster delivery timelines and improved support for its domestic and international clientele.
Source: BSE
